deadline extended to Monday, November 10 at 5PM, EST
| || |
Johns Hopkins School
Paul R. Thompson
University of Massachusetts
This theme is made up of four symposia, one scheduled each
day of the meeting, Sun – Wed. Please
read below for invited speaker and session schedule information. In addition to the invited talks listed
below, short talks will be selected from the submitted
abstracts. To be considered for a
volunteered talk in this theme, submit your abstract to an ASBMB topic category
number: 2290-2299, by the November 6th submission deadline. All volunteered abstracts will be programmed
for poster presentation. Those selected
for oral presentation will also present a poster. Programming notifications will be sent in
mid-January. We look forward to seeing
you at the Boston Convention and Exhibition Center, BCEC, March 28 – April 1,
Post-translational Modifications of Lysine
Sunday, March 29, 2015, 3:55 PM - 6:10 PM
Session Chair: Paul R. Thompson, University of Massachusetts Medical School
Philip Cole, Johns Hopkins Sch. Of Med.
Targeting reversible lysine modifications
Robert A. Copeland, Epizyme, Inc.
Protein Methyltransferase Inhibitors as Cancer Therapeutics
Dirk Schwarzer, Univ. of Tuebingen
A chemical toolbox for lysine deacetylases
Post-translational Modifications of Arginine: Methylation, Citrullination, Phosphorylation
Monday, March 30, 2015, 9:45 AM - 12:00 PM
Session Chair: Philip Cole, Johns Hopkins Sch. Of Med.
Tim Clausen, Inst. of Molecular Pathology - IMP, Vienna
No stress with pArg? About the biological role of protein arginine
Danica Galonic Fujimori, UCSF
Positive Feedback Regulation in Histone Demethylases
Paul R. Thompson, University of Massachusetts Medical School
Picking the PADlock: Chemical probes to
study the protein arginine deiminases
Post-translational Modifications of Cysteine: Lipidation and
Tuesday, March 31, 2015, 3:55 PM - 6:10 PM
Session Chair: Gerald W. Hart, Johns Hopkins Univ. Sch. Of Med.
Maurine Linder, Cornell Univ.
Mechanism and Function of DHHC Palmitoyltransferases
Brent Martin, Univ. of Michigan
Rescuing cell polarity with small molecule inhibitors of de-palmitoylation
Eranthie Weerapana, Boston Col.
A chemical-proteomic platform to investigate cysteine S-nitrosation
O-GlcNAcylatoin: How Sweet It Is
Wednesday, April 1, 2015, 9:00 AM - 11:15 AM
Session Chair: Eranthie Weerapana, Boston Col.
Donald Bers, UC, Davis
O-GlcNAcylation of CaMKII in Cardiac Myocytes can be Pro-Arrhythmic
Gerald W. Hart, Johns Hopkins Univ. Sch. Of Med.
Nutrient Regulation of Signaling & Transcription by O-GlcNAcylation
Suzanne Walker, Harvard Med. Sch.
The Split Personality of Human O-GlcNAc Transferase